Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
GLP-1 eligibility : If the medication is prescribed for a medical condition (e.g., type 2 diabetes, obesity with comorbidities), it qualifies as a reimbursable expense
Lund JN, Scholefield JH
This well-tolerated therapy is of specific interest to patients who are on oral treatments and/or basal insulin and do not manage to maintain their HbA1c targets
Among people who adhered to treatment, average weight loss was 16.6% with oral semaglutide 25 mg, compared with 2.7% with placebo
US$ 21.98
US$ 28.81
US$ 21.11
US$ 21.04
US$ 28.95
US$ 29.45
